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O B J E C T I V E S In this study we sought to explore the relationship between cardiac magnetic
resonance (CMR) with late gadolinium enhancement (LGE) and histopathological parameters including
interstitial ﬁbrosis and replacement ﬁbrosis (scar) in patients with hypertrophic cardiomyopathy (HCM).
B A C KG ROUND CMR-LGE is a well-established tool for the assessment of scar in ischemic heart
disease. Its role in HCM has evolved in recent years, and an association with nonsustained ventricular
tachycardia has been demonstrated.
METHOD S HCM patients who underwent septal myectomy during the period 2004 through 2010 and had
undergone CMR-LGE no more than 6 months before surgery were selected. Histopathological assessment of the
myectomy specimens included quantitative digital analysis (interstitial and replacement ﬁbrosis) and semiquan-
titative assessment (small intramural coronary arteriole dysplasia and disarray). Correlations between CMR-LGE
measuredwith various techniques, SD above the signal intensity for the normal remotemyocardium (2, 4, 5, 6, and
10 SD) and the full width at half maximum (FWHM) technique, at the myectomy site, and interstitial ﬁbrosis,
replacement ﬁbrosis (scar), and their sum (ﬁbrosis  scar) were evaluated.
R E S U L T S Twenty-nine patients were included. Statistically signiﬁcant correlations between CMR-LGE (at 2, 4,
5, 6, 10 SD and by the FWHM technique), and both interstitial ﬁbrosis and the combined interstitial and
replacement ﬁbrosis were found. The strongest correlation was between combined interstitial and replacement
ﬁbrosis and CMR-LGE measured at 5 SD (r  0.78, p  0.0001). LGE measured at 10 SD demonstrated the best
correlation with replacement ﬁbrosis (r  0.42, p  0.02). Bland-Altman analysis revealed optimum agreement
between the combined interstitial and replacement ﬁbrosis found at pathology and LGE measured at 4 SD. In
addition, moderate and severe small intramural coronary artery dysplasia showed a statistically signiﬁcant
correlation with replacement ﬁbrosis (p  0.01) and CMR-LGE at 10 SD (p  0.04).
CONC L U S I O N S CMR-LGE measured at 4 SD and 5 SD yields the closest approximation to the
extent of total ﬁbrosis measured by the histopathological standard of reference. These ﬁndings have
implications for future investigations of CMR-LGE and its association with important clinical endpoints
in HCM, including sudden cardiac death. (J Am Coll Cardiol Img 2013;6:587–96) © 2013 by the
American College of Cardiology Foundation
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588yocardial fibrosis commonly seen in hyper-
trophic cardiomyopathy (HCM) may con-
sist of varying degrees of both replacement
fibrosis (scarring) and interstitial fibrosis
1–4). It is distinctly different from fibrosis seen in
oronary artery disease or dilated cardiomyopathy (3) and
s usually most severe in the area of greatest myocardial
ypertrophy (1,4,5).
Cardiac magnetic resonance (CMR), in conjunc-
ion with late gadolinium enhancement (LGE), can
etect myocardial fibrosis/scarring associated with
oronary artery disease (6,7).
See page 597
Although it is generally assumed that LGE in
HCM represents myocardial fibrosis, very few stud-
ies have addressed the histopathological correlation
of imaging features (8,9). In a case report describing
an explanted heart of a patient with
HCM, Moon et al. (8) found a direct
correlation between the extent of LGE
and collagen content. In a study on a series
of HCM patients who underwent myec-
tomy, Kwon et al. (9) found a significant
correlation between myocardial fibrosis
(assessed semiquantitatively without dis-
tinction between interstitial and replace-
ment fibrosis) and LGE. Both studies
used a thresholding technique in which
the total burden of scar/fibrosis was di-
chotomized as having a signal intensity
(SI) 2 SD above that of normal remote
myocardium. Harrigan et al. (10) demon-
strated recently that a 2-SD threshold
exaggerated the true extent of fibrosis by 76%
compared with a purely visual appreciation (man-
ual) of LGE pattern. Flett et al. (11) showed that
the full width at half maximum (FWHM) tech-
nique for LGE quantification in HCM is the most
reproducible compared with the manual and SD
techniques. Therefore, the optimum threshold to
detect fibrosis in HCM compared with a histo-
pathological gold standard is currently unknown.
The purpose of our study was to examine which
quantification technique of CMR-LGE has the best
correlation/agreement with a histopathological stan-
dard of reference. A secondary aim was to see whether
it might be possible to distinguish between interstitial
and replacement fibrosis based on the SD threshold
selected. For this analysis, we studied a cohort of
HCM patients who underwent myectomy for whom
tissue samples were available for histopathology. aM E T H O D S
Population. A retrospective search of our institu-
ional database was performed for identification of
CM patients with symptomatic left ventricular
LV) outflow tract obstruction who underwent
yectomy between January 2004 and September
010 and had a CMR examination including LGE
maging performed in the 6 months preceding
urgery.
Diagnosis of HCM at our institution follows
stablished criteria with the definition of a hyper-
rophied and nondilated left ventricle in the absence
f another cardiac or systemic disease that could
esult in a similar magnitude of hypertrophy (12).
Criteria for study exclusion were LV ejection
raction 55% based on CMR assessment, angio-
raphically proven obstructive coronary artery dis-
ase (50% in at least 1 epicardial coronary artery),
r a history of myocardial infarction.
Clinical findings (pre- and post-operative), echo-
ardiographic findings, and functional CMR data
ere recorded from patients’ electronic medical
ecords. The study was approved by the institu-
ional review board, and the need for patient written
nformed consent was waived.
Echocardiography. All transthoracic echocardiogra-
hy was performed by experienced sonographers
sing commercially available ultrasound equipment
ccording to American Society of Echocardiogra-
hy guidelines (13).
Cardiac magnetic resonance. CMR was performed
on a 1.5-T whole-body scanner (Signa CV/i, GE,
Waukesha, Wisconsin) equipped with an 8-
element array coil (January 2004 through mid
2008) or a 1.5-T/3.0-T whole-body scanner
(MAGNETOM Avanto/MAGNETOM Verio,
Siemens Healthcare, Erlangen, Germany) equipped
with a 32-element dedicated cardiac array (mid
2008 through September 2010).
The standard clinical HCM CMR protocol con-
sisted of scout images followed by functional assess-
ment of the left ventricle using cine steady-state free
precession techniques. Short-axis cine steady-state
free precession stacks (encompassing the left ven-
tricle from apex to base) were performed at a slice
thickness of 6 to 8 mm (2-mm gap) with 1.3 to
1.5  1.3 to 1.5 mm in-plane resolution and 50
s temporal resolution regardless of platform/field
trength.
LGE imaging was performed subsequent to the
dministration of gadolinium-based contrast agentA B B R E V I A T I O N S
A N D A C R O N YM S
CMR cardiac magnetic
resonance
FWHM full width at half
maximum
HCM hypertrophic
cardiomyopathy
LGE late gadolinium
enhancement
LV left ventricular
SI signal intensity
SICAD small intramuralt a dose of 0.2 mmol/kg body weight using an
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589inversion recovery spoiled gradient recalled echo
sequence technique acquiring a single slice per
breath hold. Inversion time was individually opti-
mized to null normal myocardium. Slice prescrip-
tions included a short-axis stack identical to that
performed in cine steady-state free precession im-
aging as well as 2-, 3-, and 4-chamber orientations
10 min post-injection. Slice thickness for LGE
imaging was 6 to 8 mm with an in-plane resolution
of 1.3 to 1.5  1.3  1.5 mm2.
CMR data analysis. CMR data were analyzed using
ommercially available post-processing software.
V volumes, ejection fraction, myocardial mass,
nd extent of myocardial LGE were measured by
ffline analysis using CMR42 (Circle Cardiovascu-
ar Imaging, Calgary, Alberta, Canada) by a single
xperienced reader (10 years of CMR experience)
linded to clinical data and pathology findings.
Volumetric quantification was performed by
emiautomated segmentation of the endocardial
order at end-systole and end-diastole, and total
V mass was assessed by semiautomated segmen-
ation of endocardial and epicardial borders at
nd-diastole. In addition to these evaluations, the
aximal end-diastolic myocardial thickness of the
asal anteroseptal wall was measured.
The presence and amount of LGE were mea-
ured at the basal and mid-ventricular anteroseptum
evels to correspond to the portion of myocardium
emoved on myectomy. Matching of the CMR-
GE quantification area and the exact area and
olume of surgical myectomy was performed based
n surgical and pathological reports, including di-
ension and weight measurements as well as peri-
perative transesophageal echocardiography and
ost-operative CMR (where available). Prescription
f the area of myectomy on the LGE dataset being
uantified was performed by an additional observer
o avoid unblinding of the operator who performed
GE quantification.
The outer perimeter of the myectomy region was
ontoured on sequential short-axis slices on the
reoperative CMR using the standard epicardial
ontour tool. To enable a measurement of the LV
ass within the myectomy slice, a tiny internal
ontour was placed at the center of each myectomy
egion using the standard endocardial contour tool.
hus, the area between the 2 contours reflected the
ass of tissue within the myectomy site on each
lice. Two user-defined regions of interest were
hosen: 1) within normal nulled (with no enhance-
ent) remote myocardium placed outside the my-ctomy site to generate the mean and SD for thearious SDs used (14); and 2) another region of
nterest was drawn around hyperintense myocar-
ium and used to define the maximal signal for the
WHM threshold (11). A separate region of inter-
st of approximately the same size was chosen on
ach slice within the acquired LGE stack. In the
WHM technique, slices with no LGE were not
nalyzed. The mass of LGE was recorded for each
echnique (2 SD, 4 SD, 5 SD, 6 SD, 10 SD, and
WHM). A percentage of LGE within the myec-
omy site was then generated for each measure-
ent. Any areas that were identified as enhance-
ent by the software, but were thought by the
eader to represent inversion time artifact or con-
amination by blood pool/epicardial fat were ex-
luded manually by contour adjustment.
Pathology. The surgical specimens were all oriented
anatomically, formalin fixed, and paraffin embed-
ded. Transverse sections containing both the endo-
cardium and the deep myocardial margin were
taken. Orientation (base to apex) was preserved
from proximal (basal) to distal (apical) sections. The
presence of macroscopic scar was noted. Sections
were stained with hematoxylin and eosin, Movat
pentachrome, and elastic trichrome stains. Blinded
histological review of the slides and de novo analysis
based on pre-specified, standardized criteria was
conducted. Myocyte disarray, muscle fiber hyper-
trophy, and small intramural coronary arteriole
dysplasia (SICAD) were assessed using semiquan-
titative grading. The presence of hypertrophy and
disarray was graded as absent, mild when present in
1% to 25% of the tissue, moderate when present in
26% to 50%, and severe when present in 50% of
the tissue examined. Dysplastic vessels were identi-
fied using criteria previously described (1,3,4,15,16)
and included prominent luminal narrowing, medial
and intimal thickening (consisting of the prolifera-
tion of smooth muscle and collagen), and mucoid
deposits with distortion of the internal elastic mem-
brane. The relative proportion of dysplastic vessels
out of the total number of vessels per sample was
estimated and graded as absent when no dysplastic
vessels were identified, mild when 1% to 25% of the
vessels counted were dysplastic, moderate when
26% to 50% of the vessels were dysplastic, and
severe when 50% of the vessels counted were
dysplastic.
For quantitative analysis of fibrosis, elastic
trichrome–stained slides were digitally scanned (at
20 magnification) and a composite digitized im-
age was obtained using the Aperio ScanScope
software (Aperio Technologies, Inc., Vista, Califor-
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590nia). Interstitial fibrosis was defined as collagen
intermingled with myocardial tissue excluding scars,
endocardium, and large (0.5 mm) vessels. Areas
of replacement fibrosis (scar) were identified as
areas “easily distinguished from other forms of
myocardial fibrosis by their focal nature, size, shape
and distribution” (17) and were defined as foci of
uninterrupted fibrosis measuring 2 mm.
Analysis was performed using the Aperio Posi-
tive Pixel Count algorithm. A macro for the blue in
the elastic trichrome–stained sections was made and
used to quantify the amount of interstitial fibrosis in
each specimen. The relative amount of interstitial
collagen was calculated. Areas identified as replace-
ment fibrosis (scar) were manually delineated and
their fraction quantified in a similar manner.
Statistical analysis. All data were analyzed using
MedCalc software, version 11.6.1 (MedCalc Soft-
ware, Ostend, Belgium). Continuous data are pre-
sented as mean  SD. The D’Agostino-Pearson
test was used to assess distribution normality. The
Spearman rank correlation method was used to test
for association between continuous variables (due to
rejection of distribution normality in some of the
variables). The Hotelling-Williams method was
used to test for significance between dependent
correlations. Bland-Altman analysis was used to
assess the agreement between measures of fibrosis at
pathology and CMR-LGE. The differences be-
tween the 2 techniques (pathology and CMR-
LGE) were plotted against the reference method
(histopathology) (18). A Kruskal-Wallis test was
used for comparison of categorical and continuous
variables. Statistical significance was assumed at
p  0.05.
R E S U L T S
Retrospective database analysis identified 30 pa-
tients who underwent both septal myectomy and
had undergone CMR including LGE imaging
within 6 months before surgery (2.6  2 months).
One patient who had extreme values of interstitial
and replacement fibrosis (which was reflected in the
CMR-LGE results) was excluded, leaving 29 pa-
tients in the final analysis. Image quality was suffi-
cient for complete data analysis in all these patients.
The mean age at the time of surgery was 50  15
years. Clinical characteristics, volumetric CMR data,
and echocardiographic data are listed in Table 1.
Histopathology ﬁndings. Mean specimen weight was
.9  2.9 g (range 1.8 to 14.2 g) with visible
carring in 15 specimens (52%) on gross inspection.n microscopic evaluation, interstitial fibrosis was
ound and quantified in all 29 specimens (100%),
ith an average area of 14.4  4.9% (range 5.9% to
5.2%) and replacement fibrosis (scar) was detected
n 17 (59%) specimens with an extent of 1.8 2.7%
range 0.4% to 9.6%). All 29 specimens displayed
ome degree of myocyte disarray and hypertrophy.
hirteen of 29 specimens (45%) had mild disarray,
4 of 29 (48%) had moderate disarray, and 2 of 29
7%) had severe disarray. SICAD was found in 24
pecimens (83%), 15 (52%) showed mild SICAD, 7
24%) displayed moderate SICAD, and in 2 (7%),
evere SICAD was noted.
CMR-LGE ﬁndings. Mean LV mass on CMR was
175.3  63.7 g. The extent of LGE within the
yectomy site in different SDs is shown in Table 1
nd ranged from 1.9  2.2% at 10 SD to 38.5 
9.2% at 2 SD.
Histopathology:CMRcorrelationﬁndings. FIBROSIS AND
SCAR CORRELATIONS. Statistically significant cor-
relations between CMR-LGE (at all assessed
SDs and FWHM) and interstitial and total
fibrosis (combination of interstitial fibrosis 
scar) were found. A statistically significant corre-
Table 1. Characteristics of Study Population:
Clinical, Echocardiography, CMR, and Pathology Data (n  29)
Age at myectomy, yrs 50 15 (2377)
Women 11 (38)
Mean LVEF (CMR), % 65 6
Mean resting LVOT gradient, mm Hg 57 34
Mean maximum LVOT gradient, mm Hg 96 28
Mean basal interventricular septal
thickness (CMR), mm
20.1 4.0
LV mass (CMR), g 175.3 63.7
LVMI (CMR), g 91.0 30.8
CMR-LGE at 10 SD (% of myectomy site) 1.9 2.2
CMR-LGE at 6 SD (% of myectomy site) 7.8 7.7
CMR-LGE at 5 SD (% of myectomy site) 10.9 9.0
CMR-LGE at 4 SD (% of myectomy site) 16.5 12.0
CMR-LGE at 2 SD (% of myectomy site) 38.5 19.2
CMR-LGE at FWHM (% of myectomy site) 10.6 6.4
Myectomy (pathology), g 6.9 2.9
Replacement ﬁbrosis (scar) at
histopathology (% of myectomy)
1.8 2.7
Interstitial ﬁbrosis at histopathology
(% of myectomy)
14.4 4.9
Interstitial ﬁbrosis and replacement
ﬁbrosis (scar) combined at
histopathology (% of myectomy)
16.2 6.0
Values are mean  SD (range) or n (%).
CMR  cardiac magnetic resonance; FWHM  full with half maximum;
LGE  late gadolinium enhancement; LV  left ventricular; LVEF  left
ventricular ejection fraction; LVMI  left ventricular mass index; LVOT  left
ventricular outﬂow tract.lation between CMR-LGE and replacement fi-
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591brosis (scar) was found only at 10 SD. Interstitial
fibrosis displayed stronger correlations than scar.
The strongest correlation was between the com-
bination of interstitial fibrosis  scar and CMR-
LGE measured at 5 SD (r  0.78, p  0.0001).
Only a trend was found comparing the correla-
Table 2. Correlation of CMR-LGE and Myocardial Fibrosis
(Histopathology)
Spearman
Correlation 95% CI p value
2 SD: replacement ﬁbrosis 0.08 0.30 to 0.43 0.7
2 SD: interstitial ﬁbrosis 0.69 0.43 to 0.84 0.0001
2 SD: total ﬁbrosis 0.62 0.33 to 0.80 0.0003
4 SD: replacement ﬁbrosis 0.20 0.18 to 0.53 0.31
SD: interstitial ﬁbrosis 0.71 0.49 to 0.86 0.0001
4 SD: total ﬁbrosis 0.73 0.50 to 0.87 0.0001
5 SD: replacement ﬁbrosis 0.32 0.05 to 0.61 0.09
5 SD: interstitial ﬁbrosis 0.74 0.54 to 0.87 0.0001
5 SD: total ﬁbrosis 0.78 0.58 to 0.89 0.0001
6 SD: replacement ﬁbrosis 0.33 0.04 to 0.62 0.07
6 SD: interstitial ﬁbrosis 0.65 0.40 to 0.83 0.0001
6 SD: total ﬁbrosis 0.69 0.44 to 0.85 0.0001
10 SD: replacement
ﬁbrosis
0.42 0.06 to 0.68 0.02
10 SD: interstitial ﬁbrosis 0.64 0.40 to 0.82 0.0002
10 SD: total ﬁbrosis 0.69 0.45 to 0.86 0.0001
FWHM: replacement
ﬁbrosis
0.25 0.13 to 0.57 0.25
FWHM: interstitial ﬁbrosis 0.65 0.37 to 0.82 0.0001
FWHM: total ﬁbrosis 0.65 0.38 to 0.82 0.0001
CI  conﬁdence interval; other abbreviations as in Table 1.
r = 0.62
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Figure 1. Association Between Total Fibrosis on Histopathology
These Spearman rank correlation graphs demonstrate statistically si
FWHM) and the amount of total ﬁbrosis (scar and interstitial ﬁbrosi
ﬁbrosis and LGE at 5 SD (r  0.78; p  0.0001). CMR  cardiac ma
gadolinium enhancement.tions at 5 SD and 2 SD (p  0.08), but no
statistical significance was found between the
correlations at different SDs and with the
FWHM technique. Table 2 and Figure 1 sum-
marize the correlation between CMR-LGE (at
different SDs and FWHM) and myocardial fi-
brosis found at histopathology.
The Bland-Altman plots in Figure 2 show the
different levels of agreement found between LGE
at different SDs and histopathology. The stron-
gest agreement was found between the sum of
interstitial and replacement fibrosis at histopa-
thology and CMR-LGE at 4 SD (systemic bias
of 0.3%).
SICAD correlations. There was a statistically signif-
icant association between moderate and severe
SICAD and both replacement fibrosis and LGE
at 10 SD (Table 3).
Histopathology CMR correlations according to time
period. As described in the Methods section, our
data were collected over a period of time during
which a change in MR scanner and contrast me-
dium occurred. Subanalysis was performed to in-
vestigate the possibility of an era effect on the data.
During the period 2004 through mid 2008, there
were 16 included cases. The correlation between the
sum of interstitial fibrosis and scar to LGE at 5 SD
was r  0.76 (p  0.0006). During the period 2008
through 2010, there were 13 included cases. The
correlation between the sum of interstitial fibrosis and
scar to LGE at 5 SD was r  0.86 (p  0.0002).
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592D I S C U S S I O N
In the present study, we examined the correlation
between CMR and histopathology of the myec-
tomy site in patients with HCM, exploring the
presence of both interstitial and replacement fibro-
sis (see Fig. 3 for examples). Replacement fibrosis
included both macroscopic and microscopic scars.
We used an existing definition of microscopic scar
as areas 2 mm that were “easily distinguished
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Figure 2. Bland-Altman Plots Comparing Histopathology and CM
These Bland-Altman plots demonstrate better agreement between
bias of 0.3) compared with CMR-LGE at 2, 5, 6, 10 SD and at FWH
differences between the 2 techniques (pathology and CMR-LGE) we
against the mean of the 2 techniques (18). Abbreviations as in Figu
Table 3. Association Between the Degree of SICAD/Disarray
and CMR/Pathology Variables
SICAD,
p Value
Myocyte Disarray,
p Value
Age 0.30 0.01
IVS (CMR) 0.27 0.10
LV mass 0.28 0.74
LVOT maximum gradient 0.08 0.98
LGE at 2 SD 0.16 0.14
LGE at 5 SD 0.05 0.42
LGE at 10 SD 0.04 0.20
Replacement ﬁbrosis (scar), % 0.01 0.70
Interstitial ﬁbrosis, % 0.17 0.63
Replacement ﬁbrosis (scar) 
interstitial ﬁbrosis, %
0.05 0.62
IVS  interventricular septum; SICAD  small intramural coronary arteriole
dysplasia; other abbreviations as in Table 1.from other forms of myocardial fibrosis by their
focal nature, size, shape and distribution” (17). Our
data demonstrate that LGE measured at 4 SD and
5 SD above the mean SI of normal myocardium
most accurately reflects the total amount of fibrosis
(the sum of replacement fibrosis and interstitial
fibrosis) compared with histopathology. Although
the FWHM technique has previously been reported
as being the most reproducible (11), we did not find
a statistically better correlation with the percentage
of fibrosis in the myectomy samples than at 4 to 5 SD,
and there are reasons to believe that this technique is
more applicable to focal ischemic scar with well-
defined boundaries rather than the multifocal islands
of fibrosis and scar seen in HCM (19).
Importantly, we conclusively demonstrated that
not only does CMR-LGE detect macroscopic areas
of fibrosis (scar or replacement fibrosis) but also
clearly identifies more subtle areas of interstitial
fibrosis that are obvious on microscopic examination
but not on gross visual pathological examination.
Furthermore, we demonstrated that the majority of
LGE signal that is detected by CMR-LGE is in fact
predominantly due to these areas of subtle fibrosis and
not replacement fibrosis as had been previously as-
sumed. These are the first data of which we are aware
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593CMR techniques in the HCM population. Finally,
we have also demonstrated that LGE measured at 10
SD above the normal myocardial signal has the
strongest correlation with replacement fibrosis (scar).
The pathological literature on HCM includes
criteria to differentiate between interstitial and re-
placement fibrosis, and these 2 entities may repre-
sent different pathobiological processes. Our study
demonstrates that CMR-LGE is able to detect
both kinds of fibrosis, but it cannot discriminate
completely between them. It seems that LGE at
higher SDs (i.e., 10 SD) represents the denser
fibrosis that probably consists of replacement fibro-
sis but also the denser interstitial fibrosis.
The correlation between LGE measured at 2 SD
and combined fibrosis and scar was less significant
and overestimated the degree of fibrosis identified
pathologically. This overestimation of fibrosis/scar
seen at 2 SD directly reflects the problems of image
noise and suboptimal inversion time selection,
which have more influence at a 2-SD threshold
because they generally fall below the level of detec-
tion at a higher SD cutoff. A similar overestimation
at 2 SD was also noted by Harrigan et al. (10) when
compared with standard visual assessment of total
fibrosis.
CMR-LGE is established as a high-fidelity tech-
nique for the demonstration of focal myocardial
replacement scar in ischemic cardiomyopathy
(6,20). The presence of LGE has been shown in
both ischemic and nonischemic cardiomyopathy
populations to portend a poor prognosis (21,22).
HCM is pathologically distinct from ischemic car-
diomyopathy, having a high burden of more diffuse
fibrosis intermingled with healthy muscle fibers
rather than dense scarring in a vascular territory.
Relatively recently it was suggested that LGE in
HCM patients correlates with ventricular arrhythmias
(23,24), heart failure episodes (25), and wall thickness
(5,26). Application of the technique to HCM is
attractive, but accurate correlation with histopathology
is essential for meaningful interpretation.
Currently, the most accepted approach to defin-
ing the extent of LGE is to use a mathematical
function to define fibrosis as any tissue above a
pre-defined SD threshold when compared with the
SI of normal myocardium (14). Differences between
segments of the myocardium can thus be appreci-
ated on a voxel-by-voxel basis. It might be imagined
that lower voxel SI indicates only the presence of
diffuse interstitial fibrosis. However, measured SI
within a given voxel is a function of both the relative
percentages of normal versus enhancing tissue aswell as the degree of enhancement of that tissue. In
other words, mild elevations in voxel SI may reflect
the presence of diffuse mildly enhancing tissue
within the voxel. Alternatively, a voxel recording
the same SI may be due to a component of
myocardium with a much higher SI but associated
with normal unenhanced myocardium comprising
the majority of the voxel. Here the phenomenon of
partial volume results in the overall voxel SI being
measured as much lower than the peak intensity
within the voxel. This is a limitation inherent to the
spatial resolution constraints of CMR. However,
almost all of our LGE studies were of relatively
high resolution at 1.3  1.3 mm inplane.
Until now there have been few data to suggest
that LGE is sensitive enough to identify interstitial
fibrosis with reliability. The assumption was that
the regional differences in gadolinium accumulation
needed for contrast MRI readings were insufficient
in HCM (because of the diffuse nature of the
interstitial fibrosis in this disease). Nevertheless, we
were able to demonstrate interstitial fibrosis with
this technique by meticulously searching for nor-
mal, or less affected, remote myocardium and also
by comparing it with the myectomy site (our area of
interest), the area most affected by disease.
In the future, T1 mapping techniques may facil-
itate a more accurate and precise assessment of
fibrotic burden, perhaps also showing less operator
dependence (27). Although single time-point T1
mapping may substantially be influenced by con-
trast application parameters, more recently de-
scribed methods of normalization, equilibrium im-
aging, or assessment of the extracellular volume
fraction may enable easier quantification of fibrosis
(28). Further studies, however, are warranted to
optimize such imaging and post-processing tech-
niques that do not represent the current clinical
standard of care.
A causal relationship between LGE and arrhyth-
mic cardiac death has yet to be convincingly estab-
lished in HCM. Our work suggests that a reason
for this may be the relatively high percentage of
interstitial fibrosis in our myectomy samples, with
replacement fibrosis (scar) making up a much
smaller proportion of the observed potentially ar-
rhythmic substrate. Aquaro et al. (29) found that
mild enhancement was an independent predictor of
nonsustained ventricular tachycardia in HCM pa-
tients. Their assumption was that such enhance-
ment represents interstitial fibrosis that can be
associated with fiber disarray (plexiform fibrosis)
and thus potentially more arrhythmogenic than
Figu
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594gross scar. We did not demonstrate a strong corre-
lation between LGE and the amount of disarray,
however, in contrast to the strong correlation of
LGE with interstitial fibrosis. A recent study pub-
lished by Appelbaum et al. (30) found that in
patients with HCM, intermediate LGE SI is a
better predictor of ventricular arrhythmias. It is
appealing to believe that a link exists between
LGE-derived measures of fibrosis and adverse ar-
rhythmic outcome. Our data suggest that much of
what is seen to be “scar” at higher SDs is in fact
interstitial fibrosis, which is not well defined as a
source of arrhythmogenic re-entry. Further work is
required to establish the relative importance of
interstitial versus dense fibrosis/scar as a risk factor
for nonsustained ventricular tachycardia and sudden
cardiac death. In the meantime, our study provides
valuable information regarding LGE and its histo-
Figure 3. Examples of Histopathological Extent of Fibrosis and
Different Quantiﬁcation Techniques
Three cases displaying varying degrees of interstitial and replaceme
deﬁned as ﬁbrosis intermingled with myocardium. (C) Large amoun
2 mm. The CMR short-axis images demonstrate LGE depicted wit
signal intensity of normal remote myocardium and with the FWHM
contoured on sequential short-axis slices on the pre-operative CMR
of the left ventricular mass within the myectomy slice, a tiny conto
dard endocardial contour tool. A user-deﬁned region of interest wit
tomy site (blue). Another region of interest was drawn around hyp
the FWHM threshold. Areas in yellow in the myectomy site represe
(pathology) highlights the collagen ﬁbrils (stained blue) present in
stitial ﬁbrosis; RF  replacement ﬁbrosis; other abbreviations as inpathological basis substantiating the notion thatLGE measured at 4 to 5 SD reflects the presence of
both interstitial fibrosis and replacement fibrosis
(scar). Our data add to recent studies that have
attempted to define the most appropriate SDs to
use in this type of assessment.
We also found a strong association between
moderate and severe SICAD and replacement fi-
brosis (scar) as well as LGE at 10 SD. This finding
is important because it hints at a mechanism of
microvascular disease with repetitive ischemia re-
sulting eventually in formation of scar. Whether an
agent targeting the microvasculature and improving
perfusion would lead to a reduction in scar devel-
opment in the long term is an interesting specula-
tion, but currently without substantive support.
Study limitations. First, we acknowledge the difficulty
of transposing the exact dimensions of the myectomy
sample onto a series of 2-dimensional LGE slices.
-LGE Estimation of Fibrosis at
brosis. (A) Mild interstitial ﬁbrosis. (B) Severe interstitial ﬁbrosis
replacement ﬁbrosis, deﬁned as areas of uninterrupted ﬁbrosis
ay-scale thresholding techniques at 2, 4, 5, and 6 SD above mean
hnique. The outer perimeter of the myectomy region (green) was
g the standard epicardial contour tool. To enable a measurement
ed) was placed internal to the myectomy region using the stan-
normal nulled remote myocardium was placed outside the myec-
ense myocardium (pink) and used to deﬁne maximal signal for
GE at corresponding thresholds. The elastic trichrome stain
ing degrees within the myocardium (stained maroon). IF  inter-
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595and the gram weight were known at the time of
contouring. Additionally, inspection of all before and
after myectomy imaging (including perioperative
transesophageal echocardiography) was performed
wherever possible to further improve accuracy.
Second, there are inherent difficulties in identi-
fication and measurement of interstitial fibrosis
including the problem of incorrect selection of
inversion time, which may contribute “white pixel
noise.” In addition, because fibrosis may occur in
small islands rather than as a continuous sheet,
spatial resolution may be a limiting factor. We
hypothesized that use of a higher cutoff (i.e., 5 SD
rather than 2 SD) would significantly reduce the
problems of suboptimal inversion time. At our
institution we also have a policy of close staff
supervision at the time of the CMR examination to
further minimize this problem. We optimized our
inplane spatial resolution to 1.3  1.3 mm in most
cases. Further increases in spatial resolution are
challenging to achieve with a breath-hold technique
and also entrain a higher degree of noise, and
therefore the competing demands of voxel size and
signal-to-noise ratio have to be balanced.
Finally, although we have demonstrated theenhancement to irreversible injury, in-
1
1
Evaluation of technto 5 SD threshold, we recognize that a larger
sample would be required to demonstrate statistical
separation between the respective diagnostic accu-
racies of 4 to 6 SD.
C O N C L U S I O N S
In this study, we have shown that a strong correla-
tion exists between total fibrosis (the sum of re-
placement and interstitial fibrosis) and LGE when
assessed at 4 SD/5 SD above remote normal myo-
cardium. As far as we are aware, this is the first
study to show that LGE at 4 SD/5 SD has a better
correlation with histopathology than LGE at 2 SD.
These findings have implications for future investi-
gations of CMR-LGE and its association with
important clinical endpoints in HCM, including
sudden cardiac death.
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